US Court of Appeals: District of Columbia - FTC v. Boehringer Ingelheim Pharmaceuticals [Boehringer final brief]
MLex Summary: Boehringer Ingelheim has filed its final brief in the Federal Trade Commission's appeal from a decision holding that documents the agency sought to obtain from it regarding agreements with generic...To view the full article, register now.
Already a subscriber? Click here to view full article